Decoding the metastatic potential and optimal postoperative adjuvant therapy of melanoma based on metastasis score

Abstract Metastasis is a formidable challenge in the prognosis of melanoma. Accurately predicting the metastatic potential of non-metastatic melanoma (NMM) and determining effective postoperative adjuvant treatments for inhibiting metastasis remain uncertain. In this study, we conducted comprehensiv...

Full description

Bibliographic Details
Main Authors: Kangjie Shen, Wenyu Song, Hongye Wang, Lu Wang, Yang Yang, Qianrong Hu, Min Ren, Zixu Gao, Qiangcheng Wang, Shaoluan Zheng, Ming Zhu, Yanwen Yang, Yong Zhang, Chuanyuan Wei, Jianying Gu
Format: Article
Language:English
Published: Nature Publishing Group 2023-10-01
Series:Cell Death Discovery
Online Access:https://doi.org/10.1038/s41420-023-01678-6
_version_ 1797453904871424000
author Kangjie Shen
Wenyu Song
Hongye Wang
Lu Wang
Yang Yang
Qianrong Hu
Min Ren
Zixu Gao
Qiangcheng Wang
Shaoluan Zheng
Ming Zhu
Yanwen Yang
Yong Zhang
Chuanyuan Wei
Jianying Gu
author_facet Kangjie Shen
Wenyu Song
Hongye Wang
Lu Wang
Yang Yang
Qianrong Hu
Min Ren
Zixu Gao
Qiangcheng Wang
Shaoluan Zheng
Ming Zhu
Yanwen Yang
Yong Zhang
Chuanyuan Wei
Jianying Gu
author_sort Kangjie Shen
collection DOAJ
description Abstract Metastasis is a formidable challenge in the prognosis of melanoma. Accurately predicting the metastatic potential of non-metastatic melanoma (NMM) and determining effective postoperative adjuvant treatments for inhibiting metastasis remain uncertain. In this study, we conducted comprehensive analyses of melanoma metastases using bulk and single-cell RNA sequencing data, enabling the construction of a metastasis score (MET score) through diverse machine-learning algorithms. The reliability and robustness of the MET score were validated using various in vitro assays and in vivo models. Our findings revealed a distinct molecular landscape in metastatic melanoma characterized by the enrichment of metastasis-related pathways, intricate cell–cell communication, and heightened infiltration of pro-angiogenic tumor-associated macrophages compared to NMM. Importantly, patients in the high MET score group exhibited poorer prognoses and an immunosuppressive microenvironment, featuring increased infiltration of regulatory T cells and decreased infiltration of CD8+ T cells, compared to the low MET score patient group. Expression of PD-1 was markedly higher in patients with low MET scores. Anti-PD-1 (aPD-1) therapy profoundly affected antitumor immunity activation and metastasis inhibition in these patients. In summary, our study demonstrates the effectiveness of the MET score in predicting melanoma metastatic potential. For patients with low MET scores, aPD-1 therapy may be a potential treatment strategy to inhibit metastasis. Patients with high MET scores may benefit from combination therapies.
first_indexed 2024-03-09T15:29:36Z
format Article
id doaj.art-c8d5e95afefb4072ae5616eadb823832
institution Directory Open Access Journal
issn 2058-7716
language English
last_indexed 2024-03-09T15:29:36Z
publishDate 2023-10-01
publisher Nature Publishing Group
record_format Article
series Cell Death Discovery
spelling doaj.art-c8d5e95afefb4072ae5616eadb8238322023-11-26T12:21:20ZengNature Publishing GroupCell Death Discovery2058-77162023-10-019111410.1038/s41420-023-01678-6Decoding the metastatic potential and optimal postoperative adjuvant therapy of melanoma based on metastasis scoreKangjie Shen0Wenyu Song1Hongye Wang2Lu Wang3Yang Yang4Qianrong Hu5Min Ren6Zixu Gao7Qiangcheng Wang8Shaoluan Zheng9Ming Zhu10Yanwen Yang11Yong Zhang12Chuanyuan Wei13Jianying Gu14Department of Plastic Surgery, Zhongshan Hospital, Fudan UniversityDepartment of Cardiovascular Surgery, Zhongshan Hospital, Fudan UniversityDepartment of Interventional Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong UniversityDepartment of Plastic Surgery, Zhongshan Hospital, Fudan UniversityDepartment of Plastic Surgery, Zhongshan Hospital, Fudan UniversityDepartment of Plastic Surgery, Zhongshan Hospital, Fudan UniversityDepartment of Plastic Surgery, Zhongshan Hospital, Fudan UniversityDepartment of Plastic Surgery, Zhongshan Hospital, Fudan UniversityThe Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer ResearchDepartment of Plastic Surgery, Zhongshan Hospital, Fudan UniversityDepartment of Plastic Surgery, Zhongshan Hospital, Fudan UniversityDepartment of Plastic Surgery, Zhongshan Hospital, Fudan UniversityDepartment of Plastic Surgery, Zhongshan Hospital, Fudan UniversityDepartment of Plastic Surgery, Zhongshan Hospital, Fudan UniversityDepartment of Plastic Surgery, Zhongshan Hospital, Fudan UniversityAbstract Metastasis is a formidable challenge in the prognosis of melanoma. Accurately predicting the metastatic potential of non-metastatic melanoma (NMM) and determining effective postoperative adjuvant treatments for inhibiting metastasis remain uncertain. In this study, we conducted comprehensive analyses of melanoma metastases using bulk and single-cell RNA sequencing data, enabling the construction of a metastasis score (MET score) through diverse machine-learning algorithms. The reliability and robustness of the MET score were validated using various in vitro assays and in vivo models. Our findings revealed a distinct molecular landscape in metastatic melanoma characterized by the enrichment of metastasis-related pathways, intricate cell–cell communication, and heightened infiltration of pro-angiogenic tumor-associated macrophages compared to NMM. Importantly, patients in the high MET score group exhibited poorer prognoses and an immunosuppressive microenvironment, featuring increased infiltration of regulatory T cells and decreased infiltration of CD8+ T cells, compared to the low MET score patient group. Expression of PD-1 was markedly higher in patients with low MET scores. Anti-PD-1 (aPD-1) therapy profoundly affected antitumor immunity activation and metastasis inhibition in these patients. In summary, our study demonstrates the effectiveness of the MET score in predicting melanoma metastatic potential. For patients with low MET scores, aPD-1 therapy may be a potential treatment strategy to inhibit metastasis. Patients with high MET scores may benefit from combination therapies.https://doi.org/10.1038/s41420-023-01678-6
spellingShingle Kangjie Shen
Wenyu Song
Hongye Wang
Lu Wang
Yang Yang
Qianrong Hu
Min Ren
Zixu Gao
Qiangcheng Wang
Shaoluan Zheng
Ming Zhu
Yanwen Yang
Yong Zhang
Chuanyuan Wei
Jianying Gu
Decoding the metastatic potential and optimal postoperative adjuvant therapy of melanoma based on metastasis score
Cell Death Discovery
title Decoding the metastatic potential and optimal postoperative adjuvant therapy of melanoma based on metastasis score
title_full Decoding the metastatic potential and optimal postoperative adjuvant therapy of melanoma based on metastasis score
title_fullStr Decoding the metastatic potential and optimal postoperative adjuvant therapy of melanoma based on metastasis score
title_full_unstemmed Decoding the metastatic potential and optimal postoperative adjuvant therapy of melanoma based on metastasis score
title_short Decoding the metastatic potential and optimal postoperative adjuvant therapy of melanoma based on metastasis score
title_sort decoding the metastatic potential and optimal postoperative adjuvant therapy of melanoma based on metastasis score
url https://doi.org/10.1038/s41420-023-01678-6
work_keys_str_mv AT kangjieshen decodingthemetastaticpotentialandoptimalpostoperativeadjuvanttherapyofmelanomabasedonmetastasisscore
AT wenyusong decodingthemetastaticpotentialandoptimalpostoperativeadjuvanttherapyofmelanomabasedonmetastasisscore
AT hongyewang decodingthemetastaticpotentialandoptimalpostoperativeadjuvanttherapyofmelanomabasedonmetastasisscore
AT luwang decodingthemetastaticpotentialandoptimalpostoperativeadjuvanttherapyofmelanomabasedonmetastasisscore
AT yangyang decodingthemetastaticpotentialandoptimalpostoperativeadjuvanttherapyofmelanomabasedonmetastasisscore
AT qianronghu decodingthemetastaticpotentialandoptimalpostoperativeadjuvanttherapyofmelanomabasedonmetastasisscore
AT minren decodingthemetastaticpotentialandoptimalpostoperativeadjuvanttherapyofmelanomabasedonmetastasisscore
AT zixugao decodingthemetastaticpotentialandoptimalpostoperativeadjuvanttherapyofmelanomabasedonmetastasisscore
AT qiangchengwang decodingthemetastaticpotentialandoptimalpostoperativeadjuvanttherapyofmelanomabasedonmetastasisscore
AT shaoluanzheng decodingthemetastaticpotentialandoptimalpostoperativeadjuvanttherapyofmelanomabasedonmetastasisscore
AT mingzhu decodingthemetastaticpotentialandoptimalpostoperativeadjuvanttherapyofmelanomabasedonmetastasisscore
AT yanwenyang decodingthemetastaticpotentialandoptimalpostoperativeadjuvanttherapyofmelanomabasedonmetastasisscore
AT yongzhang decodingthemetastaticpotentialandoptimalpostoperativeadjuvanttherapyofmelanomabasedonmetastasisscore
AT chuanyuanwei decodingthemetastaticpotentialandoptimalpostoperativeadjuvanttherapyofmelanomabasedonmetastasisscore
AT jianyinggu decodingthemetastaticpotentialandoptimalpostoperativeadjuvanttherapyofmelanomabasedonmetastasisscore